Use of Patient and Disease Characteristics as Predictive Indicators of Rituximab Infusion-Related Reactions in Adult Malignant Hematology Patients at an Academic Medical Center

ConclusionActual body weight and bone marrow involvement may be utilized as potential predictive indicators of R-IRRs. Further study is needed to validate these indicators and determine appropriate utilization in practice.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research

Related Links:

ConclusionActual body weight and bone marrow involvement may be utilized as potential predictive indicators of R-IRR. Further research is needed to validate these indicators and determine appropriate utilization in practice.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
CONCLUSIONS: We identified potential environmental uranium exposure pathways (occupational, lifestyle related and domestic) among patients with HMs that could have resulted in increased uranium exposure. HIV is common among patients with HMs. Together with the results from a previous retrospective case series of HMs at CHBAH (2004 - 2013), our findings suggest that further research on environmental uranium exposure in mining areas and HM risk in residents is warranted. PMID: 31131802 [PubMed - in process]
Source: South African Medical Journal - Category: African Health Tags: S Afr Med J Source Type: research
In this study, we reviewed major human studies on the health risks of radiation exposure and showed that sex-related factors may potentially influence the long-term response to radiation exposure. Available data suggest that long-term radiosensitivity in women is higher than that in men who receive a comparable dose of radiation. The report on the biological effects of ionizing radiation (BEIR VII) published in 2006 by the National Academy of Sciences, United States emphasized that women may be at significantly greater risk of suffering and dying from radiation-induced cancer than men exposed to the same dose of radiation....
Source: Frontiers in Genetics - Category: Genetics & Stem Cells Source Type: research
Publication date: Available online 8 February 2016 Source:Journal of Advanced Research Author(s): Hossam K. Mahmoud, Mohamed A. Samra, Gamal M. Fathy Malignancy is the second most common cause of mortality in the reproductive period and it complicates up to one out of every 1000 pregnancies. When cancer is diagnosed during pregnancy, the management approach must take into consideration both the mother and her fetus. Hematologic cancers diagnosed in pregnancy are not common, resulting in paucity of randomized controlled trials. Diagnosis of such malignancies may be missed or delayed, as their symptoms are similar to th...
Source: Journal of Advanced Research - Category: Research Source Type: research
Publication date: Available online 8 February 2016 Source:Journal of Advanced Research Author(s): Hossam K. Mahmoud, Mohamed A. Samra, Gamal M. Fathy Malignancy is the second most common cause of mortality in the reproductive period and it complicates up to one out of every 1,000 pregnancies. When cancer is diagnosed during pregnancy, the management approach must take into consideration both the mother and her fetus. Hematologic cancers diagnosed in pregnancy are not common, resulting in paucity of randomized controlled trials. Diagnosis of such malignancies may be missed or delayed, as their symptoms are similar to t...
Source: Journal of Advanced Research - Category: Research Source Type: research
We report 5 additional cases along with a review of the existing literature. We provide a review of potential treatment regimens and approaches to the management of pregnancy during multiple myeloma.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
We report five additional cases along with a review of the existing literature. We provide a review of potential treatment regimens and approaches to the management of pregnancy during multiple myeloma.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
We report 5 additional cases along with a review of the existing literature. We provide a review of potential treatment regimens and approaches to the management of pregnancy during multiple myeloma.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Tags: Original Study Source Type: research
Conclusion We consider that the use of anthracyclines during pregnancy does not produce cardiac damage in newborns and can be safely administered, because no cardiac toxicity was evident in these children and it is of benefit to the mother. Micro-Abstract Anthracyclines are safe for fetuses of mothers who received chemotherapy, because no cardiac toxicity was observed using new echocardiographic techniques.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
Conclusions We considered that the use of anthracyclines during pregnancy, did not produce cardiac damage in the newborns and can be safely administered, because not cardiac toxicity was evident in these children and it is benefit to the mother. Teaser Anthracycicles are safely to the fetus that received chemotherapy, because no cardiac toxicity was observed ,with the new echocardiogram techniques.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
More News: Academia | Cancer & Oncology | Chemotherapy | Hematology | Leukemia | Lymphoma | Myeloma | Pregnancy | Rituxan | Study